The objective of this contract is to develop a second-generation assay for the oraquick ebola rapid antigen test as a sustainable, enhanced test including alternative reagents (antibody and antigen)…
Active Definitive Contract Awarded Last action
- Contract number
- 75A50122C00079
- Awardee
-
Orasure Technologies Inc. UEI Y79RWFLHWDM6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $15,504,106
Award facts
- Opportunity
-
- Improvement of the OraQuick Ebola Rapid Antigen Test Special Notice · 75A50122R00024 · Posted Jun 30, 2022
- Contract value 100% obligated
- $15,504,106.00 Current and potential, with all options
- Completion date 85% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Fountain Hill, PA 18015, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $6,887,258 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $8,616,848 |
About this award
This is a sole-source federal contract award to OraSure Technologies, Inc., a for-profit manufacturer of diagnostic medical testing products, to develop improvements to the OraQuick Ebola Rapid Antigen Test. The objective is to increase the test's sensitivity and shelf life, develop sustainable reagents to eliminate reliance on limited supplies, transition manufacturing to an automated line to improve quality and production speed, and purchase two lots of approximately 10,000 improved tests each. The $15,504,106.00 contract is a cost-plus-fixed-fee definitive contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. It has a period of performance through June 30, 2027 and does not utilize a set-aside designation. OraSure Technologies is the prime contractor, and the contract supports the agency's efforts to enhance critical Ebola diagnostic capabilities.
Description
The objective of this contract is to develop a second-generation assay for the oraquick ebola rapid antigen test as a sustainable, enhanced test including alternative reagents (antibody and antigen) with continued availability, extended shelf-life, a
Quick answers
Who was awarded contract 75A50122C00079?
75A50122C00079 was awarded to Orasure Technologies Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on January 3, 2023.
How much is contract 75A50122C00079 worth?
The government has obligated $15,504,106 on 75A50122C00079.
Was contract 75A50122C00079 competed?
The extent of competition for 75A50122C00079 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award